Nan Shan Life Insurance Co., Ltd. / BMY
Nan Shan Life Insurance Co., Ltd.’s Bristol-Myers Squibb Co Position
Does Nan Shan Life Insurance Co., Ltd. own Bristol-Myers Squibb Co (BMY)? Yes — 939.8K shares worth $57M (+2.06% of its 13F portfolio) as of Q1 2026.
Position Value
$57M
Q1 2026
Shares
939.8K
% of Portfolio
+2.06%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 939.8K | $57M | +2.06% |
| Q4 2025 | 939.8K | $51M | +1.56% |
| Q3 2025 | 939.8K | $42M | +0.90% |
| Q2 2025 | 941.5K | $44M | +0.97% |
| Q1 2025 | 943.6K | $58M | +1.36% |
| Q4 2024 | 943.6K | $53M | +1.28% |
| Q3 2024 | 1.28M | $66M | +1.56% |
| Q2 2024 | 1.30M | $54M | +1.28% |
| Q1 2024 | 1.33M | $72M | +1.70% |
| Q4 2023 | 1.33M | $68M | +1.65% |
| Q3 2023 | 1.33M | $77M | +2.11% |
| Q2 2023 | 1.21M | $77M | +1.86% |
| Q1 2023 | 917.4K | $64M | +1.51% |
| Q4 2022 | 595.4K | $43M | +1.17% |
| Q3 2022 | 1.17M | $83M | +2.03% |
| Q2 2022 | 561.3K | $43M | +0.91% |
| Q1 2022 | 1.56M | $114M | +1.99% |
| Q4 2021 | 1.56M | $97M | +1.47% |
| Q3 2021 | 1.23M | $73M | +1.21% |
| Q2 2021 | 961.8K | $64M | +1.09% |
| Q1 2021 | 1.27M | $80M | +1.55% |
| Q4 2020 | 1.27M | $79M | +1.63% |
| Q3 2020 | 1.27M | $76M | +2.01% |
| Q2 2020 | 1.05M | $62M | +1.87% |
| Q1 2020 | 893.1K | $50M | +1.82% |
| Q4 2019 | 893.1K | $57M | +1.79% |
| Q3 2019 | 729.7K | $37M | +1.02% |
| Q2 2019 | 736.7K | $33M | +0.85% |
| Q1 2019 | 738.7K | $35M | +0.69% |
| Q4 2018 | 786.7K | $41M | +0.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nan Shan Life Insurance Co., Ltd.’s full portfolio or all institutional holders of BMY.